Cambridge Cancer Genomics

Curated by Signal

Developer of AI-based precision medicine tools for oncologists

Overview

Developer of AI-based precision medicine tools for oncologists. The company is using a liquid biopsy to develop tools to suggest suitable therapeutic strategies for cancer patients. The AI-based platform OncOS helps oncologists to optimize their personalized treatments by searching the reported mutations in samples, clinical trial results, biomarker analysis, and more.

Key facts

Founded: 2016
Headquarters: Cambridge, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

NHS GP
Online platform for booking doctor appointment
Health TechnologyLondon, United Kingdom
Prymexa
Platform offering health monitoring solutions
Health TechnologyHereford, United Kingdom
Genie
Online community platform for people with health issues
Health TechnologySouthampton, United Kingdom

About Cambridge Cancer Genomics

What does Cambridge Cancer Genomics do?

Developer of AI-based precision medicine tools for oncologists.

Where is Cambridge Cancer Genomics headquartered?

Cambridge Cancer Genomics is headquartered in Cambridge, United Kingdom.

When was Cambridge Cancer Genomics founded?

Cambridge Cancer Genomics was founded in 2016.

Which sector is Cambridge Cancer Genomics in?

Cambridge Cancer Genomics operates in Health Technology.

Who are Cambridge Cancer Genomics's competitors?

Companies similar to Cambridge Cancer Genomics include NHS GP, Prymexa, and Genie.